Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay

Antiviral Research

Volumn 138, Issue , 2017, Pages 47-56

  Adcock, Robert S ^a   Chu, Yong Kyu ^a   Golden, Jennifer E ^b   Chung, Dong Hoon ^a,c  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; AZAURIDINE; BREQUINAR; CID 91632869; COMPACTIN; FINASTERIDE; GUANOSINE TRIPHOSPHATE; MYCOPHENOLIC ACID; NITD 008; RIBAVIRIN; SALIPHENYLHALAMIDE; TERIFLUNOMIDE; UNCLASSIFIED DRUG; VIRUS RNA; BIPHENYL DERIVATIVE;

ALPHAVIRUS; ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DOSE RESPONSE; EC50; FLAVIVIRUS; HIGH THROUGHPUT SCREENING; NONHUMAN; PRIORITY JOURNAL; PYRIMIDINE SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; VIRAL PLAQUE ASSAY; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING; ZIKA VIRUS; ANIMAL; CHLOROCEBUS AETHIOPS; DRUG DEVELOPMENT; DRUG EFFECTS; EVALUATION STUDY; HUMAN; MOLECULAR LIBRARY; PROCEDURES; VERO CELL LINE; VIROLOGY; ZIKA FEVER;

ANIMALS; ANTIVIRAL AGENTS; AZAURIDINE; BIPHENYL COMPOUNDS; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; RIBAVIRIN; SMALL MOLECULE LIBRARIES; VERO CELLS; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85003864754     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.11.018     Document Type: Article

References (63)

1. Acosta, E.G., Castilla, V., Damonte, E.B., Alternative infectious entry pathways for dengue virus serotypes into mammalian cells. Cell. Microbiol., 2009, 1533–1549.
2. Aggarwal, S., Thareja, S., Verma, A., Bhardwaj, T.R., Kumar, M., An overview on 5alpha-reductase inhibitors. Steroids, 2010, 109–153.
3. Aliota, M.T., Caine, E.A., Walker, E.C., Larkin, K.E., Camacho, E., Osorio, J.E., Characterization of Lethal Zika virus infection in AG129 mice. PLoS Negl. Trop. Dis., 10, 2016, e0004682.
4. Amet, T., Nonaka, M., Dewan, M.Z., Saitoh, Y., Qi, X., Ichinose, S., Yamamoto, N., Yamaoka, S., Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication. Microbes Infect., 2008, 471–480.
5. Barrows, N.J., Campos, R.K., Powell, S.T., Prasanth, K.R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Munoz, G., McGrath, E.L., Urrabaz-Garza, R., Gao, J., et al. A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe, 2016, 259–270.
6. Bearcroft, W.G., Zika virus infection experimentally induced in a human volunteer. Trans. R. Soc. Trop. Med. Hyg. 50 (1956), 442–448.
7. Bonavia, A., Franti, M., Pusateri Keaney, E., Kuhen, K., Seepersaud, M., Radetich, B., Shao, J., Honda, A., Dewhurst, J., Balabanis, K., et al. Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV). Proc. Natl. Acad. Sci. U. S. A., 2011, 6739–6744.
8. Bono, V.H. Jr., Weissman, S.M., Frei, E. 3rd, The effect of 6-azauridine administration on de novo pyrimidine production in chronic myelogenous leukemia. J. Clin. Investig., 1964, 1486–1494.
9. Calvet, G., Aguiar, R.S., Melo, A.S., Sampaio, S.A., de Filippis, I., Fabri, A., Araujo, E.S., de Sequeira, P.C., de Mendonca, M.C., de Oliveira, L., et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect. Dis. 16 (2016), 653–660.
10. Cao-Lormeau, V.M., Blake, A., Mons, S., Lastere, S., Roche, C., Vanhomwegen, J., Dub, T., Baudouin, L., Teissier, A., Larre, P., et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet Lond. Engl. 387 (2016), 1531–1539.
11. Carteaux, G., Maquart, M., Bedet, A., Contou, D., Brugieres, P., Fourati, S., Cleret de Langavant, L., de Broucker, T., Brun-Buisson, C., Leparc-Goffart, I., et al. Zika virus associated with meningoencephalitis. N. Engl. J. Med. 374 (2016), 1595–1596.
12. Chu, J.J., Ng, M.L., Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol., 2004, 10543–10555.
13. Chu, J.J.H., Ng, M.L., Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol. 78 (2004), 10543–10555.
14. Chung, D.H., Golden, J.E., Adcock, R.S., Schroeder, C.E., Chu, Y.K., Sotsky, J.B., Cramer, D.E., Chilton, P.M., Song, C., Anantpadma, M., et al. Discovery of a broad-spectrum antiviral compound that inhibits pyrimidine biosynthesis and establishes a type 1 interferon-independent antiviral state. Antimicrob. Agents Chemother., 2016, 4552–4562.
15. Chung, D.H., Jonsson, C.B., Maddox, C., McKellip, S.N., Moore, B.P., Heil, M., White, E.L., Ananthan, S., Li, Q., Feng, S., et al. HTS-driven discovery of new chemotypes with West Nile Virus inhibitory activity. Molecules, 2010, 1690–1704.
16. Chung, D.H., Jonsson, C.B., Tower, N.A., Chu, Y.K., Sahin, E., Golden, J.E., Noah, J.W., Schroeder, C.E., Sotsky, J.B., Sosa, M.I., et al. Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2. PLoS Pathog., 2014, e1004213.
17. Cline, J.C., Nelson, J.D., Gerzon, K., Williams, R.H., Delong, D.C., In vitro antiviral activity of mycophenolic acid and its reversal by guanine-type compounds. Appl. Microbiol. 18 (1969), 14–20.
18. Crance, J.M., Scaramozzino, N., Jouan, A., Garin, D., Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antivir. Res. 58 (2003), 73–79.
19. Crotty, S., Cameron, C.E., Andino, R., RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 6895–6900.
20. Day, C.W., Smee, D.F., Julander, J.G., Yamshchikov, V.F., Sidwell, R.W., Morrey, J.D., Error-prone replication of West Nile virus caused by ribavirin. Antivir. Res. 67 (2005), 38–45.
21. del Real, G., Jimenez-Baranda, S., Mira, E., Lacalle, R.A., Lucas, P., Gomez-Mouton, C., Alegret, M., Pena, J.M., Rodriguez-Zapata, M., Alvarez-Mon, M., et al. Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med., 2004, 541–547.
22. Deng, C.L., Yeo, H., Ye, H.Q., Liu, S.Q., Shang, B.D., Gong, P., Alonso, S., Shi, P.Y., Zhang, B., Inhibition of enterovirus 71 by adenosine analog NITD008. J. Virol., 2014, 11915–11923.
23. Diaz, M.O., Ziemin, S., Le Beau, M.M., Pitha, P., Smith, S.D., Chilcote, R.R., Rowley, J.D., Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. U. S. A., 1988, 5259–5263.
24. Dick, G.W., Zika virus. II. Pathogenicity and physical properties. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 521–534.
25. Dick, G.W., Kitchen, S.F., Haddow, A.J., Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46 (1952), 509–520.
26. Duffy, M.R., Chen, T.H., Hancock, W.T., Powers, A.M., Kool, J.L., Lanciotti, R.S., Pretrick, M., Marfel, M., Holzbauer, S., Dubray, C., et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. New Engl. J. Med. 360 (2009), 2536–2543.
27. Giguere, J.F., Tremblay, M.J., Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. J. Virol., 2004, 12062–12065.
28. Gower, T.L., Graham, B.S., Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrob. Agents Chemother., 2001, 1231–1237.
29. Hamel, R., Dejarnac, O., Wichit, S., Ekchariyawat, P., Neyret, A., Luplertlop, N., Perera-Lecoin, M., Surasombatpattana, P., Talignani, L., Thomas, F., et al. Biology of Zika virus infection in human skin cells. J. Virol. 89 (2015), 8880–8896.
30. Harmon, M.W., Janis, B., Effects of cytosine arabinoside, adenine arabinoside, and 6-azauridine on rabies virus in vitro and in vivo. J. Infect. Dis. 133 (1976), 7–13.
31. Hoffmann, H.H., Kunz, A., Simon, V.A., Palese, P., Shaw, M.L., Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc. Natl. Acad. Sci. U. S. A., 2011, 5777–5782.
32. Kalia, M., Khasa, R., Sharma, M., Nain, M., Vrati, S., Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J. Virol., 2013, 148–162.
33. Kolokoltsov, A.A., Fleming, E.H., Davey, R.A., Venezuelan equine encephalitis virus entry mechanism requires late endosome formation and resists cell membrane cholesterol depletion. Virology 347 (2006), 333–342.
34. Lanciotti, R.S., Lambert, A.J., Holodniy, M., Saavedra, S., Signor, L.d.C.C., Phylogeny of Zika virus in Western Hemisphere, 2015. Emerg. Infect. Dis. 22 (2016), 933–935.
35. Lazear, H.M., Govero, J., Smith, A.M., Platt, D.J., Fernandez, E., Miner, J.J., Diamond, M.S., A mouse model of Zika virus pathogenesis. Cell Host Microbe 19 (2016), 720–730.
36. Liu, S., Neidhardt, E.A., Grossman, T.H., Ocain, T., Clardy, J., Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents. Struct. Lond. Engl. 1993, 2000, 25–33.
37. Liu, S., Rodriguez, A.V., Tosteson, M.T., Role of simvastatin and methyl-beta-cyclodextrin [corrected] on inhibition of poliovirus infection. Biochem. Biophys. Res. Co., 2006, 51–59.
38. Lo, M.K., Shi, P.Y., Chen, Y.L., Flint, M., Spiropoulou, C.F., In vitro antiviral activity of adenosine analog NITD008 against tick-borne flaviviruses. Antivir. Res., 2016, 46–49.
39. Lucas-Hourani, M., Dauzonne, D., Jorda, P., Cousin, G., Lupan, A., Helynck, O., Caignard, G., Janvier, G., Andre-Leroux, G., Khiar, S., et al. Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. PLoS Pathog., 2013, e1003678.
40. Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C., Kirchhausen, T., Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell, 2006, 839–850.
41. Markland, W., McQuaid, T.J., Jain, J., Kwong, A.D., Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob. Agents Chemother. 44 (2000), 859–866.
42. Mayor, S., Pagano, R.E., Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 8 (2007), 603–612.
43. Muller, K.H., Kainov, D.E., El Bakkouri, K., Saelens, X., De Brabander, J.K., Kittel, C., Samm, E., Muller, C.P., The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections. Br. J. Pharmacol., 2011, 344–357.
44. Perera-Lecoin, M., Meertens, L., Carnec, X., Amara, A., Flavivirus entry receptors: an update. Viruses 6 (2013), 69–88.
45. Potena, L., Frascaroli, G., Grigioni, F., Lazzarotto, T., Magnani, G., Tomasi, L., Coccolo, F., Gabrielli, L., Magelli, C., Landini, M.P., et al. Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. Circulation, 2004, 532–536.
46. PubChem CID 91632869 PubChem Database.
47. Rossi, S.L., Tesh, R.B., Azar, S.R., Muruato, A.E., Hanley, K.A., Auguste, A.J., Langsjoen, R.M., Paessler, S., Vasilakis, N., Weaver, S.C., Characterization of a novel murine model to study Zika virus. Am. J. Trop. Med. Hyg. 94 (2016), 1362–1369.
48. Rubin, E.J., Greene, M.F., Baden, L.R., Zika virus and microcephaly. N. Engl. J. Med., 2016.
49. Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., Cassone, A., New insights into the antiviral effects of chloroquine. Lancet Infect. Dis. 6 (2006), 67–69.
50. Schaar, H.M.v.d., Rust, M.J., Chen, C., Ende-Metselaar, H.v.d., Wilschut, J., Zhuang, X., Smit, J.M., Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog., 4, 2008, e1000244.
51. Simpson, D.I., Zika virus infection in man. Trans. R. Soc. Trop. Med. Hyg. 58 (1964), 335–338.
52. Smee, D.F., Hurst, B.L., Day, C.W., D282, a non-nucleoside inhibitor of influenza virus infection that interferes with de novo pyrimidine biosynthesis. Antivir. Chem. Chemother., 2012, 263–272.
53. Smit, J.M., Moesker, B., Rodenhuis-Zybert, I., Wilschut, J., Flavivirus cell entry and membrane fusion. Viruses 3 (2011), 160–171.
54. Snell, N.J.C., Ribavirin - current status of a broad spectrum antiviral agent. Expert Opin. Pharmacother. 2 (2001), 1317–1324.
55. Tacklind, J., Fink, H.A., Macdonald, R., Rutks, I., Wilt, T.J., Finasteride for benign prostatic hyperplasia. Cochrane Database Syst. Rev., 2010 CD006015.
56. Wahlberg, J.M., Garoff, H., Membrane fusion process of Semliki Forest virus. I: low pH-induced rearrangement in spike protein quaternary structure precedes virus penetration into cells. J. Cell Biol., 1992, 339–348.
57. Wang, Q.Y., Bushell, S., Qing, M., Xu, H.Y., Bonavia, A., Nunes, S., Zhou, J., Poh, M.K., Florez de Sessions, P., Niyomrattanakit, P., et al. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J. Virol., 2011, 6548–6556.
58. Xie, X.S., Padron, D., Liao, X., Wang, J., Roth, M.G., De Brabander, J.K., Salicylihalamide A inhibits the V0 sector of the V-ATPase through a mechanism distinct from bafilomycin A1. J. Biol. Chem., 2004, 19755–19763.
59. Xu, M., Lee, E.M., Wen, Z., Cheng, Y., Huang, W.K., Qian, X., Tcw, J., Kouznetsova, J., Ogden, S.C., Hammack, C., et al. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat. Med., 2016, 1101–1107.
60. Xu, M., Lee, E.M., Wen, Z., Cheng, Y., Huang, W.K., Qian, X., Tcw, J., Kouznetsova, J., Ogden, S.C., Hammack, C., et al. (2016b). qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells (PubChem).
61. Ye, J., Wang, C., Sumpter, R. Jr., Brown, M.S., Goldstein, J.L., Gale, M. Jr., Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc. Natl. Acad. Sci. U. S. A., 2003, 15865–15870.
62. Yin, Z., Chen, Y.-L., Schul, W., Wang, Q.-Y., Gu, F., Duraiswamy, J., Kondreddi, R.R., Niyomrattanakit, P., Lakshminarayana, S.B., Goh, A., et al. An adenosine nucleoside inhibitor of dengue virus. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 20435–20439.
63. Zhang, J.H., Chung, T.D., Oldenburg, K.R., A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen., 1999, 67–73.